Bupivacaine %0.25 (isobaric)

PreclinicalSmall molecule

Bupivacaine %0.25 (isobaric) is one of 88 small molecule programs targeting Lung Disease. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Lung DiseaseActive, not recruiting

HysterectomyActive, not recruiting

AnesthesiaCompleted

Pain ManagementCompleted

Hemodynamic StabilityNot yet recruiting

Arthroscopic SurgeryNot yet recruiting

Lung DiseasePreclinical

Active, not recruiting

HysterectomyPreclinical

Active, not recruiting

AnesthesiaPreclinical

Completed

Pain ManagementPreclinical

Completed

Hemodynamic StabilityPreclinical

Not yet recruiting

Arthroscopic SurgeryPreclinical

Not yet recruiting

Competition

Competitive Landscape

49 competitors in Hysterectomy

#DrugCompanyPhaseTrials

Toradol

Roche

Approved

2 2

Medrol

Pfizer

Approved

1 3

Atarax

Pfizer

Approved

1 4

Golytely

Bayer

Approved

1 5

MS Contin

HHikma Pharmaceuticals LLC

Approved

8 6

Marcaine

IInnocoll

Approved

8 7

Oxycontin

PProtega

Approved

6 8

Lyrica

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Approved

5 9

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Approved

5 10

Xylocaine

MMEDRx USA, Inc.

Approved

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

PreclinicalNot yet recruiting

Arthroscopic Surgery

NCT07688395

Post-ApprovalNot yet recruiting

Arthroscopic Shoulder Surgeries

NCT07256938

Clinical

Trials by Indication[1]

Post Operative Pain2 trials

Vaginal Cuff Bupivacaine Injection for Postoperative Pain

Completed·HHavva Betül Bacak·N/A·NCT07426666·48 enrolled

Ultrasound Guided Techniques for Postoperative Analgesia in Patients Undergoing Open Upper Abdominal Surgeries: External Oblique Intercostal Plane Block vs. Quadratus Lumborum Block; A Randomized Controlled Trial

Completed·CCairo University·Preclinical·NCT07094386·80 enrolled

Cesarean Delivery1 trial

Maternal Satisfaction After Spinal Anesthesia for Cesarean Delivery

Not yet recruiting·UUniversity of Novi Sad··NCT07438171·200 enrolled

Hysterectomy1 trial

Bupivacaine for Postoperative Pain After Laparoscopic Hysterectomy

Recruiting·SSerkan Kumbasar·N/A·NCT07435909·120 enrolled

Hemodynamic Stability1 trial

Effect of Patient Position on Bupivacaine Dose Requirement and Hemodynamic Stability in Spinal Anesthesia

Not yet recruiting·—·N/A·NCT07376798·100 enrolled

Lung Disease1 trial

Thoracic Spinal Versus Epidural Anesthesia for Nephrectomy in Obstructive/Restrictive Lung Disease Patients

Completed·NNazmy Edward Seif·N/A·NCT03324490·60 enrolled

6 more indications

Arthroscopic Shoulder Surgeries1 trial

Effect of Clonidine Additive to suprascapular_ Costoclavicular Versus Standard Interscalene Block in Arthroscopic Shoulder Surgeries

Not yet recruiting·—·Phase 4·NCT07256938·60 enrolled

Anesthesia1 trial

The Effect of Epidural Anesthesia on Optic Nerve Sheath Diameter Measurements in Total Knee Prosthesis Surgery

Completed·—·N/A·NCT07458321·60 enrolled

Postoperative Pain Relief1 trial

Postoperative Pain Relief in Children: Comparing Caudal Bupivacaine Alone Versus Bupivacaine With Dexmedetomidine for Infra-Umbilical Surgeries Under General Anesthesia

Completed·—·Phase 4·NCT07121764·60 enrolled

Pain Control1 trial

iPACK Block vs. Periarticular Infiltration for TKA Pain Control

Not yet recruiting·TTurgutlu State Hospital·N/A·NCT07267650·100 enrolled

Pain Management1 trial

Transversus Abdominis Plane Block Versus Ilioinguinal Nerve Block for Pain Management in Inguinal Herniorraphy

Completed·—·N/A·NCT02375100·90 enrolled

Arthroscopic Surgery1 trial

Novel Analgesic Approaches in Shoulder Surgery: Erector Spinae Plane Block Versus Infraspinatus-Teres Minor Interfascial Plane Block

Not yet recruiting·TTaksim Egitim ve Arastirma Hastanesi·Preclinical·NCT07688395·100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 12 trial records for Bupivacaine %0.25 (isobaric). U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Bupivacaine %0.25 (isobaric) compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Bupivacaine %0.25 (isobaric). EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Novi Sad company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity of Novi Sad

Bupivacaine %0.25 (isobaric)

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2027

Trials by Indication[1]

Post Operative Pain2 trials

Cesarean Delivery1 trial

Hysterectomy1 trial

Hemodynamic Stability1 trial

Lung Disease1 trial

Arthroscopic Shoulder Surgeries1 trial

Anesthesia1 trial

Postoperative Pain Relief1 trial

Pain Control1 trial

Pain Management1 trial

Arthroscopic Surgery1 trial

References

Drug Info

Quick Facts

Related News